Latest1 information on COVID-19

Clinical Trials Contact

About this Clinical Trial

A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

Your Message Will Go To

Paige Nicole Baker

+1 650-736-1252


All fields are required. *

Preferred contact method*

To:

Paige Nicole Baker

+1 650-736-1252



Go Back To The Trial

We were not able to send your contact info at this time.

Go Back To The Trial

©2022 Stanford Medicine